clinical trial · NCT07525427
Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis
Gates Medical Research Institute·phase2·not yet recruiting·n = 150
Drug Susceptible Pulmonary TuberculosisBedaquiline, pretomanid and TBD09Bedaquiline, pretomanid and TBD09Bedaquiline, pretomanid and TBD09Bedaquiline, pretomanid and TBD09Bedaquiline, pretomanid and linezolid
brief summary
The purpose of this study is to evaluate if TBD09 in combination with other active agents in adults with drug sensitive pulmonary tuberculosis has potential to be safe and effective.
started
Apr 10, 2026
primary completion
Nov 5, 2026
completion
Nov 5, 2026
last updated
Apr 21, 2026
official title
A Phase 2, Open-Label, Multi-Group, Controlled, Randomized Trial of the Safety, Bactericidal Activity, and Pharmacokinetics of TBD09 in Combination With Other Active Agents in Adults With Drug-Sensitive Pulmonary Tuberculosis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol